PMID- 28464523 OWN - NLM STAT- MEDLINE DCOM- 20180723 LR - 20211204 IS - 1864-0648 (Electronic) IS - 1864-063X (Linking) VI - 10 IP - 12 DP - 2017 Dec TI - Low-level light emitting diode therapy promotes long-term functional recovery after experimental stroke in mice. PG - 1761-1771 LID - 10.1002/jbio.201700038 [doi] AB - We aimed to investigate the effects of low-level light emitting diode therapy (LED-T) on the long-term functional outcomes after cerebral ischemia, and the optimal timing of LED-T initiation for achieving suitable functional recovery. Focal cerebral ischemia was induced in mice via photothrombosis. These mice were assigned to a sham-operated (control), ischemic (vehicle), or LED-T group [initiation immediately (acute), 4 days (subacute) or 10 days (delayed) after ischemia, followed by once-daily treatment for 7 days]. Behavioral outcomes were assessed 21 and 28 days post-ischemia, and histopathological analysis was performed 28 days post-ischemia. The acute and subacute LED-T groups showed a significant improvement in motor function up to 28 days post-ischemia, although no brain atrophy recovery was noted. We observed proliferating cells (BrdU(+) ) in the ischemic brain, and significant increases in BrdU(+) /GFAP(+) , BrdU(+) /DCX(+) , BrdU(+) /NeuN(+) , and CD31(+) cells in the subacute LED-T group. However, the BrdU(+) /Iba-1(+) cell count was reduced in the subacute LED-T group. Furthermore, the brain-derived neurotrophic factor (BDNF) was significantly upregulated in the subacute LED-T group. We concluded that LED-T administered during the subacute stage had a positive impact on the long-term functional outcome, probably via neuron and astrocyte proliferation, blood vessel reconstruction, and increased BDNF expression. Picture: The rotarod test for motor coordination showed that acute and subacute LED-T improves long-term functional recovery after cerebral ischemia. CI - (c) 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. FAU - Lee, Hae In AU - Lee HI AD - Department of Rehabilitation Medicine, School of Medicine, Pusan National University, Yangsan, Gyeongnam, 50612, Republic of Korea. AD - Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Gyeongnam, 50612, Republic of Korea. FAU - Lee, Sae-Won AU - Lee SW AD - Department of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan, Gyeongnam, 50612, Republic of Korea. AD - Graduate Training Program of Korean Medicine for Healthy-Aging, Pusan National University, Yangsan, Gyeongnam, 50612, Republic of Korea. AD - Korean Medical Science Research Center for Healthy-Aging, Pusan National University, Yangsan, Gyeongnam, 50612, Republic of Korea. FAU - Kim, Nam Gyun AU - Kim NG AD - Medical Research Center of Color Seven, Seoul, 06719, Republic of Korea. FAU - Park, Kyoung-Jun AU - Park KJ AD - Medical Research Center of Color Seven, Seoul, 06719, Republic of Korea. FAU - Choi, Byung Tae AU - Choi BT AD - Department of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan, Gyeongnam, 50612, Republic of Korea. AD - Graduate Training Program of Korean Medicine for Healthy-Aging, Pusan National University, Yangsan, Gyeongnam, 50612, Republic of Korea. AD - Korean Medical Science Research Center for Healthy-Aging, Pusan National University, Yangsan, Gyeongnam, 50612, Republic of Korea. FAU - Shin, Yong-Il AU - Shin YI AD - Department of Rehabilitation Medicine, School of Medicine, Pusan National University, Yangsan, Gyeongnam, 50612, Republic of Korea. AD - Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Gyeongnam, 50612, Republic of Korea. FAU - Shin, Hwa Kyoung AU - Shin HK AD - Department of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan, Gyeongnam, 50612, Republic of Korea. AD - Graduate Training Program of Korean Medicine for Healthy-Aging, Pusan National University, Yangsan, Gyeongnam, 50612, Republic of Korea. AD - Korean Medical Science Research Center for Healthy-Aging, Pusan National University, Yangsan, Gyeongnam, 50612, Republic of Korea. LA - eng PT - Journal Article DEP - 20170502 PL - Germany TA - J Biophotonics JT - Journal of biophotonics JID - 101318567 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Dcx protein, mouse) RN - 0 (Doublecortin Protein) SB - IM MH - Animals MH - Astrocytes/pathology/radiation effects MH - Brain Ischemia/metabolism/pathology/*physiopathology/*therapy MH - Brain-Derived Neurotrophic Factor/metabolism MH - Cell Differentiation/radiation effects MH - Cell Proliferation/radiation effects MH - Disease Models, Animal MH - Doublecortin Protein MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Microglia/pathology/radiation effects MH - Neurons/pathology/radiation effects MH - Phototherapy/*instrumentation MH - Recovery of Function/*radiation effects MH - Stroke/*physiopathology/*therapy MH - Time Factors OTO - NOTNLM OT - BDNF OT - Functional recovery OT - focal cerebral ischemia OT - neurotrophic factor OT - photostimulation OT - post-stroke EDAT- 2017/05/04 06:00 MHDA- 2018/07/24 06:00 CRDT- 2017/05/03 06:00 PHST- 2017/02/14 00:00 [received] PHST- 2017/03/06 00:00 [revised] PHST- 2017/03/10 00:00 [accepted] PHST- 2017/05/04 06:00 [pubmed] PHST- 2018/07/24 06:00 [medline] PHST- 2017/05/03 06:00 [entrez] AID - 10.1002/jbio.201700038 [doi] PST - ppublish SO - J Biophotonics. 2017 Dec;10(12):1761-1771. doi: 10.1002/jbio.201700038. Epub 2017 May 2.